Buckle up, CG Oncology (NASDAQ: CGON) investors, because things are about to get bumpy...in the best way possible! Today, Wall...
Cretostimogene grenadenorepvec
Can gene therapy conquer bladder cancer? Explore the promise of CG Oncology’s (CGON) lead candidate, cretostimogene grenadenorepvec.
